Mira-y-Lopez R - Search Results

1

Dominant negative retinoic acid receptor initiates tumor formation in mice.

Kupumbati TS, Cattoretti G, Marzan C, Farias EF, Taneja R, Mira-y-Lopez R. Kupumbati TS, et al. Among authors: mira y lopez r. Mol Cancer. 2006 Mar 24;5:12. doi: 10.1186/1476-4598-5-12. Mol Cancer. 2006. PMID: 16563162 Free PMC article.

2

Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells.

Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-Y-Lopez R. Farias EF, et al. Among authors: mira y lopez r. Cell Growth Differ. 2002 Aug;13(8):335-41. Cell Growth Differ. 2002. PMID: 12193472

3

Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization.

Farias EF, Marzan C, Mira-y-Lopez R. Farias EF, et al. Among authors: mira y lopez r. Oncogene. 2005 Feb 24;24(9):1598-606. doi: 10.1038/sj.onc.1208347. Oncogene. 2005. PMID: 15608670

4

Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity.

Farias EF, Ong DE, Ghyselinck NB, Nakajo S, Kuppumbatti YS, Mira y Lopez R. Farias EF, et al. Among authors: mira y lopez r. J Natl Cancer Inst. 2005 Jan 5;97(1):21-9. doi: 10.1093/jnci/dji004. J Natl Cancer Inst. 2005. PMID: 15632377

5

Adipocyte derived paracrine mediators of mammary ductal morphogenesis controlled by retinoic acid receptors.

Marzan CV, Kupumbati TS, Bertran SP, Samuels T, Leibovitch B, Mira-y-Lopez R, Ossowski L, Farias EF. Marzan CV, et al. Among authors: mira y lopez r. Dev Biol. 2011 Jan 15;349(2):125-36. doi: 10.1016/j.ydbio.2010.10.018. Epub 2010 Oct 23. Dev Biol. 2011. PMID: 20974122 Free PMC article.

6

Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.

Lu Y, Bertran S, Samuels TA, Mira-y-Lopez R, Farias EF. Lu Y, et al. Among authors: mira y lopez r. Oncogene. 2010 Jun 24;29(25):3665-76. doi: 10.1038/onc.2010.119. Epub 2010 May 10. Oncogene. 2010. PMID: 20453882 Free PMC article.

7

The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells.

Jing Y, Waxman S, Mira-y-Lopez R. Jing Y, et al. Cancer Res. 1997 May 1;57(9):1668-72. Cancer Res. 1997. PMID: 9135005

8

Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.

Arapshian A, Bertran S, Kuppumbatti YS, Nakajo S, Mira-y-Lopez R. Arapshian A, et al. Among authors: mira y lopez r. Mol Cancer. 2004 Apr 27;3:13. doi: 10.1186/1476-4598-3-13. Mol Cancer. 2004. PMID: 15113415 Free PMC article.

9

Cellular retinol-binding protein expression and breast cancer.

Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira-Y-Lopez R. Kuppumbatti YS, et al. J Natl Cancer Inst. 2000 Mar 15;92(6):475-80. doi: 10.1093/jnci/92.6.475. J Natl Cancer Inst. 2000. PMID: 10716965

10

Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.

Lu M, Mira-y-Lopez R, Nakajo S, Nakaya K, Jing Y. Lu M, et al. Among authors: mira y lopez r. Oncogene. 2005 Jun 23;24(27):4362-9. doi: 10.1038/sj.onc.1208661. Oncogene. 2005. PMID: 15870697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters